Cargando…
PPARγ Networks in Cell Signaling: Update and Impact of Cyclic Phosphatidic Acid
Lysophospholipid (LPL) has long been recognized as a membrane phospholipid metabolite. Recently, however, the LPL has emerged as a candidate for diagnostic and pharmacological interest. LPLs include lysophosphatidic acid (LPA), alkyl glycerol phosphate (AGP), cyclic phosphatidic acid (cPA), and sphi...
Autor principal: | Tsukahara, Tamotsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582055/ https://www.ncbi.nlm.nih.gov/pubmed/23476786 http://dx.doi.org/10.1155/2013/246597 |
Ejemplares similares
-
A Review of Cyclic Phosphatidic Acid and Other Potential Therapeutic Targets for Treating Osteoarthritis
por: Tsukahara, Tamotsu, et al.
Publicado: (2023) -
Cyclic Phosphatidic Acid Stimulates cAMP Production and Inhibits Growth in Human Colon Cancer Cells
por: Tsukahara, Tamotsu, et al.
Publicado: (2013) -
Release of Cyclic Phosphatidic Acid from Gelatin-based Hydrogels Inhibit Colon Cancer Cell Growth and Migration
por: Tsukahara, Tamotsu, et al.
Publicado: (2012) -
Lysophospholipid-Related Diseases and PPARγ Signaling Pathway
por: Tsukahara, Tamotsu, et al.
Publicado: (2017) -
Cyclic phosphatidic acid relieves osteoarthritis symptoms
por: Gotoh, Mari, et al.
Publicado: (2014)